MedPath

Yeshurun Moshe

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.

Phase 3
Conditions
Mucositis
Transplant-Related Disorder
Interventions
First Posted Date
2021-02-16
Last Posted Date
2021-02-16
Lead Sponsor
moshe yeshurun
Target Recruit Count
116
Registration Number
NCT04756622

Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

Phase 2
Conditions
Acute-graft-versus-host Disease
Interventions
First Posted Date
2015-03-19
Last Posted Date
2015-03-19
Lead Sponsor
moshe yeshurun
Target Recruit Count
10
Registration Number
NCT02392780
Locations
🇮🇱

Davidof Cancer Center, Beilinson hospital, Rabin medical center, Petach Tikva, Israel

Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation

Phase 2
Conditions
Pediatric Patients Undergoing Allogeneic Cord Blood Transplantation.
Interventions
First Posted Date
2013-09-12
Last Posted Date
2015-06-16
Lead Sponsor
moshe yeshurun
Target Recruit Count
20
Registration Number
NCT01940562
Locations
🇮🇱

Hadassah hospital, Jerusalem, Israel

🇮🇱

Schneider Children's Medical Center of Israel, Petah Tikva, Israel

© Copyright 2025. All Rights Reserved by MedPath